<DOC>
	<DOC>NCT00978055</DOC>
	<brief_summary>The objective of this study was to investigate the bioequivalence of Mylan's liothyronine sodium 50 mcg tablets to King's Cytomel® 50 mcg tablets following a single, oral 100 mcg (2 x 50 mcg) dose administration under fasting conditions.</brief_summary>
	<brief_title>Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel® Tablets (50 Mcg)</brief_title>
	<detailed_description />
	<criteria>healthy males and/or nonpregnant, nonlactating females, 18 years and older able to swallow medication institutionalized subjects history of any significant disease use of any prescription or OTC medications within 14 days prior to start of study received any investigational products within 30 days prior to start of study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>